-
1
-
-
0029852797
-
Rethinking immunosuppression in terins of the redundant and nonredundant steps in the immune
-
Dec
-
Hallorun PF. Rethinking immunosuppression in terins of the redundant and nonredundant steps in the immune Transplanl Proc 1996 Dec: 28 (6) 1 Suppl: 11-8.
-
(1996)
Transplanl Proc
, vol.28
, Issue.1-6 SUPPL.
, pp. 11-18
-
-
Hallorun, P.F.1
-
2
-
-
50349104499
-
Mycophenolic acid - An antibiotic from Penicillium breviconipaction
-
Florey HW, Gilliver K, Jennings MA, et al. Mycophenolic acid - an antibiotic from Penicillium breviconipaction. Lancet 1946; 1: 46-9
-
(1946)
Lancet
, vol.1
, pp. 46-49
-
-
Florey, H.W.1
Gilliver, K.2
Jennings, M.A.3
-
3
-
-
0025281073
-
Bioavailability improvement of mycophenolic acid through aminoester derivatization
-
Feb
-
Lee WA, Gu L, Mikszial AR, et al. Bioavailability improvement of mycophenolic acid through aminoester derivatization. Pharm Res 1990 Feb; 7 (2): 161-6
-
(1990)
Pharm Res
, vol.7
, Issue.2
, pp. 161-166
-
-
Lee, W.A.1
Gu, L.2
Mikszial, A.R.3
-
4
-
-
0014688690
-
Mycophenolic acid: An anti-cancer compound with unusual properties
-
Aug 23
-
Carter SB, Franklin TJ, Jones DF, et al. Mycophenolic acid: an anti-cancer compound with unusual properties. Nature 1969 Aug 23; 223 (208):848-50
-
(1969)
Nature
, vol.223
, Issue.208
, pp. 848-850
-
-
Carter, S.B.1
Franklin, T.J.2
Jones, D.F.3
-
5
-
-
0014303621
-
Mycophenolic acid: Antiviral and antitumor properties
-
Jul
-
Williams RH, Lively DH, Delong DC, et al. Mycophenolic acid: antiviral and antitumor properties. J Antibiot 1968 Jul; 21 (7): 463-4
-
(1968)
J Antibiot
, vol.21
, Issue.7
, pp. 463-464
-
-
Williams, R.H.1
Lively, D.H.2
Delong, D.C.3
-
6
-
-
0017745250
-
Mycophenolic acid for psoriasis
-
Sep
-
Lynch WS, Roenigk Jr HH, Mycophenolic acid for psoriasis. Arch Dermutol 1977 Sep; 113 (9): 1203-8
-
(1977)
Arch Dermutol
, vol.113
, Issue.9
, pp. 1203-1208
-
-
Lynch, W.S.1
Roenigk Jr., H.H.2
-
7
-
-
0023630355
-
Mycophenolic acid for psoriasis: A review of pharmacology, long term efficacy, and safely
-
Dec
-
Epinette WW, Parker CM, Jones EL, et al. Mycophenolic acid for psoriasis: a review of pharmacology, long term efficacy, and safely. J Am Acad Dermatol 1987 Dec; 17 (6): 962-71
-
(1987)
J Am Acad Dermatol
, vol.17
, Issue.6
, pp. 962-971
-
-
Epinette, W.W.1
Parker, C.M.2
Jones, E.L.3
-
8
-
-
0027156705
-
Therapy of rheumatoid arthritis with mycophcnolatc mofetil
-
Goldblum R. Therapy of rheumatoid arthritis with mycophcnolatc mofetil. Clin Exp Rheumatol 1993; 11 (8 Suppl.): 117-95
-
(1993)
Clin Exp Rheumatol
, vol.11
, Issue.8 SUPPL.
, pp. 117-195
-
-
Goldblum, R.1
-
10
-
-
0014546166
-
The inhibition of nucleic acid synthesis by mycophenolic acid
-
Jul
-
Franklin TJ, Cook JM, The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 1969 Jul; 113 (3): 515-24
-
(1969)
Biochem J
, vol.113
, Issue.3
, pp. 515-524
-
-
Franklin, T.J.1
Cook, J.M.2
-
11
-
-
0023279580
-
Purification, characterization. and kinetic analysis of inosine 5'-monophosphate Uchydrogenase of trichomonas foetus
-
May
-
Verham R, Meek TD, Hedstrom L, et al. Purification, characterization. and kinetic analysis of inosine 5'-monophosphate Uchydrogenase of trichomonas foetus. Mol Biochem Parasitol 1987 May; 24 (1): 1-12
-
(1987)
Mol Biochem Parasitol
, vol.24
, Issue.1
, pp. 1-12
-
-
Verham, R.1
Meek, T.D.2
Hedstrom, L.3
-
12
-
-
0024943116
-
Prolongation of rat heart allograft survival of RS61443
-
Morris RH, Hoyt EG, Eugui FM, et al. Prolongation of rat heart allograft survival of RS61443. Surg Forum 1989; 40: 337-8
-
(1989)
Surg Forum
, vol.40
, pp. 337-338
-
-
Morris, R.H.1
Hoyt, E.G.2
Eugui, F.M.3
-
13
-
-
0025981270
-
RS-61443: A new. potent immunosuppressivc agent
-
Jan
-
Platz KP, Sollingcr HW, Hullett DA, et al. RS-61443: a new. potent immunosuppressivc agent. Transplantation 1991 Jan; 51 (1): 27-31
-
(1991)
Transplantation
, vol.51
, Issue.1
, pp. 27-31
-
-
Platz, K.P.1
Sollingcr, H.W.2
Hullett, D.A.3
-
14
-
-
0027527571
-
A long term study of allogeneic rat hind limb transplants immunosuppressed with RS-61443
-
Oct
-
Benhaim P, Anthony JP, Lin LY, et al. A long term study of allogeneic rat hind limb transplants immunosuppressed with RS-61443. Transplantation 1993 Oct; 56 (4): 911-7
-
(1993)
Transplantation
, vol.56
, Issue.4
, pp. 911-917
-
-
Benhaim, P.1
Anthony, J.P.2
Lin, L.Y.3
-
15
-
-
0028032807
-
Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil
-
Nov
-
O'Hair DP, McManus RA, Komorowski R, Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil. Ann Thorac Surg 1994 Nov; 58 (5): 1311-5
-
(1994)
Ann Thorac Surg
, vol.58
, Issue.5
, pp. 1311-1315
-
-
O'Hair, D.P.1
McManus, R.A.2
Komorowski, R.3
-
16
-
-
0000508723
-
Mycophenolate mofetil (RS-61443): Mechanisms of action and effects in transplantation
-
Jul
-
Allison AC, Eugui EM, Sollinger HW. Mycophenolate mofetil (RS-61443): mechanisms of action and effects in transplantation. Transplant Rev 1993 Jul; 7 (3): 129-39
-
(1993)
Transplant Rev
, vol.7
, Issue.3
, pp. 129-139
-
-
Allison, A.C.1
Eugui, E.M.2
Sollinger, H.W.3
-
17
-
-
0027717956
-
Characterization of human type I and type II IMP dehydrogenases
-
Carr SF, Papp E, Wu JC, et al. Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 1993; 268: 27286-90
-
(1993)
J Biol Chem
, vol.268
, pp. 27286-27290
-
-
Carr, S.F.1
Papp, E.2
Wu, J.C.3
-
18
-
-
0017352667
-
Consequences of inhibition of guaninc nucleotide synthesis by mycophenolic acid and virazole
-
Mar
-
Lowe JK, Brox L, Henderson JF. Consequences of inhibition of guaninc nucleotide synthesis by mycophenolic acid and virazole. Cancer Res 1977 Mar; 37 (3): 736-43
-
(1977)
Cancer Res
, vol.37
, Issue.3
, pp. 736-743
-
-
Lowe, J.K.1
Brox, L.2
Henderson, J.F.3
-
19
-
-
85036488555
-
-
CelICept (mycophenolute mofetil) product information. June 1995. Hoffman-La Roche Inc., Nutley, NJ 07110-1199. USA
-
CelICept (mycophenolute mofetil) product information. June 1995. Hoffman-La Roche Inc., Nutley, NJ 07110-1199. USA
-
-
-
-
20
-
-
0029917782
-
Pharmacokineties of myeophenolate mofelil (RS61443): A short review
-
Apr
-
Bullingham RE, Nicholls A, Hale M. Pharmacokineties of myeophenolate mofelil (RS61443): a short review. Transplant Proc 1996 Apr; 28 (2): 925-9
-
(1996)
Transplant Proc
, vol.28
, Issue.2
, pp. 925-929
-
-
Bullingham, R.E.1
Nicholls, A.2
Hale, M.3
-
21
-
-
34249770076
-
Mycophenolate mofetil: Molecular mechanisms of action
-
Wu JC, Mycophenolate mofetil: molecular mechanisms of action. Perspect Drug Discovery Design 1994; 2: 185-204
-
(1994)
Perspect Drug Discovery Design
, vol.2
, pp. 185-204
-
-
Wu, J.C.1
-
22
-
-
0028895151
-
Mycophenolate mofetil: A report of the consensus panel
-
Shaw LM, Sollinger HW, Halloran P, et al. Mycophenolate mofetil: a report of the consensus panel. Ther Drug Monit 1995; 17 (6): 690-9
-
(1995)
Ther Drug Monit
, vol.17
, Issue.6
, pp. 690-699
-
-
Shaw, L.M.1
Sollinger, H.W.2
Halloran, P.3
-
23
-
-
0028862437
-
Mycophenolic acid: Measurement and relationship to pharmacologic effects
-
Shaw LM, Nowak I. Mycophenolic acid: measurement and relationship to pharmacologic effects. Ther Drug Monit 1995; 17 (6): 685-9
-
(1995)
Ther Drug Monit
, vol.17
, Issue.6
, pp. 685-689
-
-
Shaw, L.M.1
Nowak, I.2
-
24
-
-
0029865220
-
Pharmacokinetics of oral mycophenolate mofetil in volunteer subjects with vary- Ing degrees or hepatic oxidative impairment
-
Apr
-
Parker G, Bullingham R, Kamm B, et al. Pharmacokinetics of oral mycophenolate mofetil in volunteer subjects with vary- ing degrees or hepatic oxidative impairment. J Clin Phurmacol 1996 Apr; 36 (4): 332-41
-
(1996)
J Clin Phurmacol
, vol.36
, Issue.4
, pp. 332-341
-
-
Parker, G.1
Bullingham, R.2
Kamm, B.3
-
25
-
-
0344697498
-
Unexpected augmentation of MMF pharmacokinetics in renal transplant patients receiving Prograf and CellCent in combination therapy and analogous in vitro findings
-
Aug 25-30: Barcelona
-
Zucker K, Esqucnazi V, Rosen A, et al. Unexpected augmentation of MMF pharmacokinetics in renal transplant patients receiving Prograf and CellCent in combination therapy and analogous in vitro findings [abstract]. Intemational Congress of the Transplantation Society; 1996 Aug 25-30: Barcelona. 60
-
(1996)
Intemational Congress of the Transplantation Society
, pp. 60
-
-
Zucker, K.1
Esqucnazi, V.2
Rosen, A.3
-
26
-
-
0026034886
-
Lymphocyte selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion
-
Feb
-
Eugui EM, Almquist S, Muller CD, et al. Lymphocyte selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991 Feb; 33 (2): 161-73
-
(1991)
Scand J Immunol
, vol.33
, Issue.2
, pp. 161-173
-
-
Eugui, E.M.1
Almquist, S.2
Muller, C.D.3
-
27
-
-
0026031530
-
Inhibition of human B-cell responses in vitro by RS-61443. cyelosporine A. and DAB486IL-2
-
Feb
-
Grailer A, Nichols J, Hullett D, et al. Inhibition of human B-cell responses in vitro by RS-61443. cyelosporine A. and DAB486IL-2. Transplant Proc 1991 Feb; 23 (1): 314-5
-
(1991)
Transplant Proc
, vol.23
, Issue.1
, pp. 314-315
-
-
Grailer, A.1
Nichols, J.2
Hullett, D.3
-
28
-
-
0029588451
-
Reduced human IgG anti-Atgam antibody formation in renal transplant recipients receiving mycophenolate mufetil
-
Dec 27
-
Kimball JA, Pescovitx MD, Book BK, et al. Reduced human IgG anti-Atgam antibody formation in renal transplant recipients receiving mycophenolate mufetil. Transplantation 1995 Dec 27; 60 (12): 1379-83
-
(1995)
Transplantation
, vol.60
, Issue.12
, pp. 1379-1383
-
-
Kimball, J.A.1
Pescovitx, M.D.2
Book, B.K.3
-
29
-
-
0027094084
-
Comparison of the effects of mizoribine with those of azathioprine 6-mereaptopurine and mycophenolic acid on T-lymphocyte proliferation and purine ribonueleotide metabolism
-
Apr
-
Dayton JS, Turka LA, Thompson CB, et al. Comparison of the effects of mizoribine with those of azathioprine 6-mereaptopurine and mycophenolic acid on T-lymphocyte proliferation and purine ribonueleotide metabolism. Mol Pharmacol 1992 Apr; 41: 671-6
-
(1992)
Mol Pharmacol
, vol.41
, pp. 671-676
-
-
Dayton, J.S.1
Turka, L.A.2
Thompson, C.B.3
-
30
-
-
0025087579
-
Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halls heart alIograft rejection by selective inhibition of T and B cell purine synthesis
-
Aug
-
Morris RE, Hoyt EG, Murphy MP, et al. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halls heart alIograft rejection by selective inhibition of T and B cell purine synthesis. Transplant Proc 1990 Aug; 22: 1659-62
-
(1990)
Transplant Proc
, vol.22
, pp. 1659-1662
-
-
Morris, R.E.1
Hoyt, E.G.2
Murphy, M.P.3
-
31
-
-
0027732959
-
New small molecule immunosuppressants for transplantation: Review of essential concepts
-
Nov-Dec
-
Morris RE, New small molecule immunosuppressants for transplantation: review of essential concepts. J Heart Lung Transplant 1993 Nov-Dec; 12 (6 Pt 2): 275-86
-
(1993)
J Heart Lung Transplant
, vol.12
, Issue.6 PART 2
, pp. 275-286
-
-
Morris, R.E.1
-
32
-
-
0026003086
-
RS-61443 for reversal of acute rejection in canine renal allografts
-
Oct
-
Platz KP, Eckhoff DE, Bechstein WO. et al. RS-61443 for reversal of acute rejection in canine renal allografts. Surgery 1991 Oct; 110:736-41
-
(1991)
Surgery
, vol.110
, pp. 736-741
-
-
Platz, K.P.1
Eckhoff, D.E.2
Bechstein, W.O.3
-
33
-
-
0027419734
-
Effects of immunosuppressive therapy on the rat aortic allograft model
-
Feb
-
Steele DM, Hullett DA, Bechstein WO, et al. Effects of immunosuppressive therapy on the rat aortic allograft model. Transplant Proc 1993 Feb; 25 (1 Pt 1): 754-5
-
(1993)
Transplant Proc
, vol.25
, Issue.1 PART 1
, pp. 754-755
-
-
Steele, D.M.1
Hullett, D.A.2
Bechstein, W.O.3
-
34
-
-
0029812955
-
Pharmacodynamic assessment of mycophenolic acid induced immunosuppression in renal transplant recipients
-
Sep 15
-
Langman LJ, Legatt DF Halloran PF, et al. Pharmacodynamic assessment of mycophenolic acid induced immunosuppression in renal transplant recipients. Transplantation 1996 Sep 15; 62 (5): 666-72
-
(1996)
Transplantation
, vol.62
, Issue.5
, pp. 666-672
-
-
Langman, L.J.1
Legatt, D.F.2
Halloran, P.F.3
-
35
-
-
0026568756
-
RS-61443: A phase I clinical trial and pilot rescue study
-
Feb
-
Sollinger HW, Deierhoi MH, Belzer FO, et al. RS-61443: a phase I clinical trial and pilot rescue study. Transplantation 1992 Feb; 53 (2): 428-32
-
(1992)
Transplantation
, vol.53
, Issue.2
, pp. 428-432
-
-
Sollinger, H.W.1
Deierhoi, M.H.2
Belzer, F.O.3
-
36
-
-
0026787479
-
RS-61443 (mycophenolate mofetil): A mullicenter study for refractory kidney transplant rejection
-
Oct
-
Sollinger HW, Belzer FO, Deierhoi MH, et al. RS-61443 (mycophenolate mofetil: a mullicenter study for refractory kidney transplant rejection. Ann Surg 1992 Oct; 216 (4): 513-9
-
(1992)
Ann Surg
, vol.216
, Issue.4
, pp. 513-519
-
-
Sollinger, H.W.1
Belzer, F.O.2
Deierhoi, M.H.3
-
37
-
-
0029006409
-
Placebo controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
-
May 27
-
European Mycophenolate Mofetil Cooperative Study Group. Placebo controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995 May 27; 345: 1321-5
-
(1995)
Lancet
, vol.345
, pp. 1321-1325
-
-
-
38
-
-
0029919822
-
Mycophenolate mofetil for maintenance therapy in kidney transplantation
-
Gonwa TA, Mycophenolate mofetil for maintenance therapy in kidney transplantation. Clin Transplant 1996; 10: 128-30
-
(1996)
Clin Transplant
, vol.10
, pp. 128-130
-
-
Gonwa, T.A.1
-
39
-
-
0006986048
-
A blinded, randomized clinical trial of mycophenolate mofotil for the prevention of acute rejection in cadaveric renal transplantation
-
Apr 15
-
Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofotil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996 Apr 15; 61 (7): 1029-37
-
(1996)
Transplantation
, vol.61
, Issue.7
, pp. 1029-1037
-
-
-
40
-
-
0029115531
-
Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
-
Aug 15
-
Sollinger HW, U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995 Aug 15; 60 (3): 225-32
-
(1995)
Transplantation
, vol.60
, Issue.3
, pp. 225-232
-
-
Sollinger, H.W.1
-
41
-
-
0029837983
-
Update on preclinical and clinical experience with myeophenolate mofetil
-
Dec
-
Sollinger HW, Update on preclinical and clinical experience with myeophenolate mofetil. Transplant Prix: 1996 Dec; 28 (6) Suppl. 1:24-9
-
(1996)
Transplant Prix
, vol.28
, Issue.6 SUPPL. 1
, pp. 24-29
-
-
Sollinger, H.W.1
-
42
-
-
0026021835
-
Early rejection: Determining the fate of renal transplants
-
Feb
-
Cecka JM, Early rejection: determining the fate of renal transplants. Transplant Proc 1991 Feb; 23 (2 Pt 1): 1263-4
-
(1991)
Transplant Proc
, vol.23
, Issue.2 PART 1
, pp. 1263-1264
-
-
Cecka, J.M.1
-
43
-
-
58149205695
-
Determinants of long term renal allograft survival
-
Jul
-
Naimark DM, Cole E, Determinants of long term renal allograft survival. Transplant Rev 1994 Jul; 8 (3): 93
-
(1994)
Transplant Rev
, vol.8
, Issue.3
, pp. 93
-
-
Naimark, D.M.1
Cole, E.2
-
44
-
-
0027196975
-
Early versus late acute renal allograft rejection: Impact on chronic rejection
-
May
-
Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993 May; 55: 933-5
-
(1993)
Transplantation
, vol.55
, pp. 933-935
-
-
Basadonna, G.P.1
Matas, A.J.2
Gillingham, K.J.3
-
45
-
-
0029922910
-
Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection
-
Mar 15
-
Mycophenolate Mofetil Renal Refractory Rejection Study Group. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. Transplantation 1996 Mar 15: 61 (5): 722-9
-
(1996)
Transplantation
, vol.61
, Issue.5
, pp. 722-729
-
-
-
46
-
-
0025875138
-
Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and non-human primate recipients of heart allografts
-
Apr 23
-
Morris RE, Wang J, Blum JR, et al. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and non-human primate recipients of heart allografts. Transplant Proc 1991 Apr 23; Suppl. 2: 19-25
-
(1991)
Transplant Proc
, vol.2 SUPPL.
, pp. 19-25
-
-
Morris, R.E.1
Wang, J.2
Blum, J.R.3
-
47
-
-
0027480924
-
Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785)
-
Feb
-
Hullett DA, Kawamura T, Fujino Y, et al. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785). Transplant Proc 1993 Feb; 25 (1): 700-1
-
(1993)
Transplant Proc
, vol.25
, Issue.1
, pp. 700-701
-
-
Hullett, D.A.1
Kawamura, T.2
Fujino, Y.3
-
48
-
-
0028227356
-
Efficacy of rapamycin. RS-61443 and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts
-
Jun
-
Yatscoff RW, Wang S, Keenan R, Efficacy of rapamycin. RS-61443 and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts. Transplant Proc l994 Jun; 26 (3): 1271-3
-
(1994)
Transplant Proc
, vol.26
, Issue.3
, pp. 1271-1273
-
-
Yatscoff, R.W.1
Wang, S.2
Keenan, R.3
-
49
-
-
0027416957
-
Hamster-to-rat heart and liver xenotrunsplantation with FK 506 plus antiproliferation drugs
-
Apr
-
Murase N, StarzI TE, Demetris AJ, et al. Hamster-to-rat heart and liver xenotrunsplantation with FK 506 plus antiproliferation drugs. Transplantation 1993 Apr; 55: 701-8
-
(1993)
Transplantation
, vol.55
, pp. 701-708
-
-
Murase, N.1
Starzi, T.E.2
Demetris, A.J.3
-
50
-
-
0027317348
-
The use of mycophenolate mofetil (RS-61443) in human heart recipients
-
Jul
-
Ensley RD, Bristow MR, Olsen SL, et al. The use of mycophenolate mofetil (RS-61443) in human heart recipients. Transplantation 1993 Jul; 56 (1): 75-82
-
(1993)
Transplantation
, vol.56
, Issue.1
, pp. 75-82
-
-
Ensley, R.D.1
Bristow, M.R.2
Olsen, S.L.3
-
51
-
-
0028342882
-
Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): Initial clinical experience
-
MayJun
-
Kirklin J, Bourge RC, Naftel DC, et al. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience. J Heart Lung Transplant 1994 MayJun; 13 (3): 444-50
-
(1994)
J Heart Lung Transplant
, vol.13
, Issue.3
, pp. 444-450
-
-
Kirklin, J.1
Bourge, R.C.2
Naftel, D.C.3
-
52
-
-
0029871188
-
Mycophenolate mofetil (MMF) in heart transplantation: Rejection prevention and treatment
-
Renlund DG, Gopinathon SK, Kfoury AG, et al. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment. Clin Transplant 1996; 10: 136-9
-
(1996)
Clin Transplant
, vol.10
, pp. 136-139
-
-
Renlund, D.G.1
Gopinathon, S.K.2
Kfoury, A.G.3
-
53
-
-
0027529361
-
RS-61443/ cyclosporine combination therapy prolongs canine liver allograft survival
-
Feb
-
Bechstein WO, Schilling M, Steele DM, et al. RS-61443/ cyclosporine combination therapy prolongs canine liver allograft survival. Transplant Proc 1993 Feb; 25 Pt 1: 702-3
-
(1993)
Transplant Proc
, vol.25
, Issue.1 PART
, pp. 702-703
-
-
Bechstein, W.O.1
Schilling, M.2
Steele, D.M.3
-
55
-
-
0027154959
-
Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplant
-
Apr
-
Freise CE, Hebert M, Osorio RW, et al. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplant. Transplant Proc 1993 Apr; 25 (2): 1758-9
-
(1993)
Transplant Proc
, vol.25
, Issue.2
, pp. 1758-1759
-
-
Freise, C.E.1
Hebert, M.2
Osorio, R.W.3
-
56
-
-
1842408531
-
Mycophenolate mofetil for prophylaxis against rejection following orthotopic liver transplantation
-
Aug 28-Sep 2: Kyoto
-
Hebert M, Lake J, Linna TJ, et al. Mycophenolate mofetil for prophylaxis against rejection following orthotopic liver transplantation [abstract]. 15th World Congress of the Transplantation Society; 1994 Aug 28-Sep 2: Kyoto. 343
-
(1994)
15th World Congress of the Transplantation Society
, pp. 343
-
-
Hebert, M.1
Lake, J.2
Linna, T.J.3
-
57
-
-
0025321482
-
RS-61443 allows islet allografting and specific tolerance in adult mice
-
Apr
-
Hao L, Lafferty AJ, Allison AC, et al. RS-61443 allows islet allografting and specific tolerance in adult mice. Transplant Proc 1990 Apr; 22: 876-9
-
(1990)
Transplant Proc
, vol.22
, pp. 876-879
-
-
Hao, L.1
Lafferty, A.J.2
Allison, A.C.3
-
58
-
-
0029918384
-
Prolongation of pancreas allograft survival by mycophenolate mofetil in the rat
-
Apr.
-
Qi S, Chen H, Xu D, et al. Prolongation of pancreas allograft survival by mycophenolate mofetil in the rat. Transplant Proc 1996 Apr. 28 (2): 932-3
-
(1996)
Transplant Proc
, vol.28
, Issue.2
, pp. 932-933
-
-
Qi, S.1
Chen, H.2
Xu, D.3
-
59
-
-
85036482484
-
Decreased rejection in simultaneous pancreas-kidney (SPK) transplantation with mycophenolate mofetil (MM): A randomized trial of lacrolimus and cyclosporine
-
May 26-29; Dallas
-
Slogall MD, Simon M, Wachs M, et al. Decreased rejection in simultaneous pancreas-kidney (SPK) transplantation with mycophenolate mofetil (MM): a randomized trial of lacrolimus and cyclosporine [abstract]. American Society of Transplant Physicians 15th Annual Meeting: 1996 May 26-29; Dallas
-
(1996)
American Society of Transplant Physicians 15th Annual Meeting
-
-
Slogall, M.D.1
Simon, M.2
Wachs, M.3
-
60
-
-
0027480555
-
Prolongation of canine intestinal allograft survival with RS-61443. cyclosporine and prodnione
-
Apr
-
D'ulessandro AM, Rankin M, McVey J, et al. Prolongation of canine intestinal allograft survival with RS-61443. cyclosporine and prodnione. Transplantation 1993 Apr; 55 (4): 695-701
-
(1993)
Transplantation
, vol.55
, Issue.4
, pp. 695-701
-
-
D'ulessandro, A.M.1
Rankin, M.2
McVey, J.3
-
61
-
-
0029788067
-
Use of Murkov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients
-
Aug
-
Lewis RL, Canafax DM, Pettit KG, et al. Use of Murkov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients. Transplant Proc 1996 Aug; 28 (4): 2214-7
-
(1996)
Transplant Proc
, vol.28
, Issue.4
, pp. 2214-2217
-
-
Lewis, R.L.1
Canafax, D.M.2
Pettit, K.G.3
-
63
-
-
10344258539
-
Economic contribution of mofotiI mycophenolate as preventive immunosuppressive treatment after renal transplantation from cadaver
-
Nov 2
-
Louis-Tonizer C, Nuijten MJ, Bayle E et al. Economic contribution of mofotiI mycophenolate as preventive immunosuppressive treatment after renal transplantation from cadaver. Presse Med 1996 Nov 2; 25 (33): 1577-82
-
(1996)
Presse Med
, vol.25
, Issue.33
, pp. 1577-1582
-
-
Louis-Tonizer, C.1
Nuijten, M.J.2
Bayle, E.3
-
65
-
-
0031016377
-
Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients
-
Feb
-
Aroldi A, Tarantino A, Montagnino G, et al. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients. Transplantation 1997 Feb; 63 (3): 380-6
-
(1997)
Transplantation
, vol.63
, Issue.3
, pp. 380-386
-
-
Aroldi, A.1
Tarantino, A.2
Montagnino, G.3
-
66
-
-
0028348583
-
The deleterious effects of long-term cyclosporin A, cyclosnorin G and FK506 on bone mineral metabolism in vivo
-
Apr
-
Cvetkovic M, Mann G, Romero D, et al. The deleterious effects of long-term cyclosporin A, cyclosnorin G and FK506 on bone mineral metabolism in vivo. Transplantation 1994 Apr; 57 (8): 1231-7
-
(1994)
Transplantation
, vol.57
, Issue.8
, pp. 1231-1237
-
-
Cvetkovic, M.1
Mann, G.2
Romero, D.3
-
67
-
-
0029817346
-
Toxic effects of immunosuppressive drugs: Mechanisms and strategies for controlling them
-
Shaw LM, Kaplan B, Kaufman D, Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them. Clin Chem I996; 42 (8B): 1316-21
-
(1996)
Clin Chem
, vol.42
, Issue.8 B
, pp. 1316-1321
-
-
Shaw, L.M.1
Kaplan, B.2
Kaufman, D.3
-
68
-
-
0024546671
-
Cyclosporine nephrotoxieily
-
6K. Steinmuller DR, Cyclosporine nephrotoxieily. Cleve Clin J Mod 1989; 56: 89-95
-
(1989)
Cleve Clin J Mod
, vol.56
, pp. 89-95
-
-
Steinmuller, D.R.1
|